title: Commentary on ZD1839 (Iressa) in non small cell lung cancer.
authors.affiliation: CR-UK Department of Medical Oncology, Christie Hospital NHS Trust, University of Manchester, Wilmslow Road, Manchester, M20 4BX, UK. malcolm.ranson@man.ac.uk
authors.forename: M
authors.initials: M
authors.lastname: Ranson
authors.forename: N
authors.initials: N
authors.lastname: Thatcher
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D011505:Protein-Tyrosine Kinases; D000077156:Gefitinib